Biological
ACAM2000 clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 1
- first study started
- 2003
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2003 (2)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2010 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 1
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Vaccination (1)
Studies
Open first, then newest update. How each study uses ACAM2000 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated AdultsCompletedPhase 2Emergent BioSolutionsNCT00053482Written as ACAM2000 Smallpox Vaccine
- VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIVCompletedPhase 3Emergent BioSolutionsNCT01158157Written as ACAM2000
- VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIVCompletedPhase 4Emergent BioSolutionsNCT02443623Written as Vaccination with ACAM2000
- Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox VaccinationCompletedPhase 2Emergent BioSolutionsNCT00053495Written as Vaccinia virus: ACAM2000 smallpox vaccine
Given in every arm · 1 — ACAM2000 is usual care beside what is tested
Codes
What other systems call ACAM2000 · ClinicalTrials.gg INT000008
- RxNorm 1492300One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 1492300 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.